Novo Nordisk NVO has stumbled through 2025, with its shares down 41.5% year to date despite finally resolving U.S. supply constraints for its semaglutide-based GLP-1 blockbusters — Ozempic for type II ...

CVS Caremark, one of the nation's largest pharmacy benefit managers, will pay the Oklahoma Attorney General's Office $5 ...

Birmingham, Alabama, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Curaechoice, the nation’s #1 leader in No-Cost Benefits Optimization Solutions, announced today that it has selected CVS Caremark at its pharmacy ...

CVS's pharmacy benefit manager, Caremark, is accused of driving independent pharmacies out of business and inflating drug costs. Federal agencies and judges have found CVS at fault for fraudulent ...

Zepbound (tirzepatide) is a brand-name injection prescribed for weight loss, weight management, and more. You may need to take Zepbound for several months to see the full effects of the drug for ...

Zepbound’s Changing the Threads exhibit in Manhattan’s uber-chic Soho area was unlike anything I’d seen before. As soon as I stepped inside, I was greeted with a flood of green lights and projections.

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse. A more ...

When I walked into Zepbound’s Changing the Threads exhibit in New York City, the first thing I noticed were the clothes suspended around the space. And no, I wasn’t paying much attention to the ...

Intracranial electroencephalography measured the brain activity of a patient with obesity and loss-of-control eating after taking tirzepatide (Zepbound), showing the medication suppressed brain ...

Novo Nordisk on Monday lowered the direct-to-consumer prices of its weight loss drug Wegovy and diabetes treatment Ozempic in a challenge to Eli Lilly’s Zepbound after President Donald Trump announced ...

The 150-year-old drugmaker is the first company in health care to hit the milestone. By Rebecca Robbins Eli Lilly, the maker of hugely popular weight loss drugs, has reached $1 trillion in value, ...